PL3091005T3 - Pochodna 1,2-naftochinonu i sposób jej wytwarzania - Google Patents

Pochodna 1,2-naftochinonu i sposób jej wytwarzania

Info

Publication number
PL3091005T3
PL3091005T3 PL14877254T PL14877254T PL3091005T3 PL 3091005 T3 PL3091005 T3 PL 3091005T3 PL 14877254 T PL14877254 T PL 14877254T PL 14877254 T PL14877254 T PL 14877254T PL 3091005 T3 PL3091005 T3 PL 3091005T3
Authority
PL
Poland
Prior art keywords
preparing same
naphthoquinone derivative
naphthoquinone
derivative
preparing
Prior art date
Application number
PL14877254T
Other languages
English (en)
Inventor
Whee Seong Lee
Mi Jung Lee
Bo Jung KIM
Tae Cheul Roh
Seung Hoon Lee
Kyu Dae Lee
You-Hui Lee
Tae Hwan Kwak
Original Assignee
Huen Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Huen Co., Ltd. filed Critical Huen Co., Ltd.
Publication of PL3091005T3 publication Critical patent/PL3091005T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/60Naphthoxazoles; Hydrogenated naphthoxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C221/00Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL14877254T 2013-12-30 2014-12-30 Pochodna 1,2-naftochinonu i sposób jej wytwarzania PL3091005T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20130166912 2013-12-30
PCT/KR2014/013038 WO2015102369A1 (ko) 2013-12-30 2014-12-30 1,2 나프토퀴논 유도체 및 이의 제조방법
EP14877254.4A EP3091005B1 (en) 2013-12-30 2014-12-30 1,2-naphthoquinone derivative and method for preparing same

Publications (1)

Publication Number Publication Date
PL3091005T3 true PL3091005T3 (pl) 2021-04-19

Family

ID=53493651

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14877254T PL3091005T3 (pl) 2013-12-30 2014-12-30 Pochodna 1,2-naftochinonu i sposób jej wytwarzania

Country Status (10)

Country Link
US (1) US10927085B2 (pl)
EP (1) EP3091005B1 (pl)
JP (1) JP6903266B2 (pl)
KR (1) KR101739362B1 (pl)
CN (1) CN106103417B (pl)
AU (1) AU2014374601B2 (pl)
CA (1) CA2935319C (pl)
DK (1) DK3091005T3 (pl)
PL (1) PL3091005T3 (pl)
WO (1) WO2015102369A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105130936B (zh) * 2015-09-01 2017-09-26 中国药科大学 一类邻萘醌化合物、其制备方法和医药用途
US11717511B2 (en) 2018-04-09 2023-08-08 Huen Co., Ltd. Pharmaceutical composition comprising derivative compound of 1,2-naphthoquinone for preventing or treating solid cancer or blood cancer
KR20190118118A (ko) 2018-04-09 2019-10-17 영진약품 주식회사 1,2-나프토퀴논 유도체 화합물을 포함하는 고형암 또는 혈액암의 예방 또는 치료용 약학 조성물
KR102247694B1 (ko) 2019-05-31 2021-05-03 주식회사 엘마이토테라퓨틱스 나프토퀴논 또는 벤조인다졸 화합물을 유효성분으로 포함하는 염증성 질환 치료용 약학적 조성물
CN111559991B (zh) * 2020-06-01 2022-01-25 河南省锐达医药科技有限公司 一种萘胺类化合物及其盐的制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080047959A (ko) * 2006-11-27 2008-05-30 주식회사 엠디바이오알파 비만, 당뇨, 대사성 질환, 퇴행성 질환 및 미토콘드리아이상 질환의 치료 또는 예방을 위한 나프토퀴논계 약제조성물
KR101468449B1 (ko) * 2007-04-26 2014-12-04 주식회사 케이티앤지생명과학 신규한 페난스렌퀴논계 화합물 및 이를 포함하는대사증후군 질환의 치료 또는 예방용 약제 조성물

Also Published As

Publication number Publication date
CA2935319A1 (en) 2015-07-09
EP3091005B1 (en) 2020-11-11
US20160376243A1 (en) 2016-12-29
CA2935319C (en) 2022-07-19
KR20150080425A (ko) 2015-07-09
JP6903266B2 (ja) 2021-07-14
EP3091005A4 (en) 2017-05-17
WO2015102369A1 (ko) 2015-07-09
US10927085B2 (en) 2021-02-23
AU2014374601B2 (en) 2019-05-23
EP3091005A1 (en) 2016-11-09
CN106103417B (zh) 2019-08-06
AU2014374601A1 (en) 2016-06-30
KR101739362B1 (ko) 2017-06-09
DK3091005T3 (da) 2020-12-21
CN106103417A (zh) 2016-11-09
JP2017501204A (ja) 2017-01-12

Similar Documents

Publication Publication Date Title
ZA201604328B (en) 1,2-naphthoquinone derivative and method for preparing same
EP3006415A4 (en) PROCESS FOR PRODUCING NANOCEMENT AND NANOCEMENT
IL241046A0 (en) Fertilizer composition and method for its preparation
EP2995281A4 (en) STENT, METHOD FOR THE PRODUCTION THEREOF AND DEVICE FOR THE PRODUCTION THEREOF
EP2962752A4 (en) VESICLE CONTAINING A SUBSTANCE, AND PROCESS FOR PRODUCING THE SAME
GB201406038D0 (en) Autotroph-based deodorizer and method for manufacturing the same
HK1205214A1 (zh) 鑽土設備及鑽土方法
EP3017149A4 (en) WEARING SURFACE AND METHOD FOR MANUFACTURING THE SAME
EP3032307A4 (en) Imaging device, imaging method and program
IL242437B (en) Compound 9, 5-dimethyl-9-hydroxy-decan-4-al, its use and its preparation process
ZA201601343B (en) Vancomycin derivative, and preparation method and application thereof
EP2946002A4 (en) LUBRICANT COMPOSITION AND METHOD FOR THE PRODUCTION THEREOF
EP3040754A4 (en) Imaging device, method, and program
EP3001465A4 (en) Light-emitting element and method for preparing same
PL3068728T3 (pl) Domieszkowany hydroksy-fosforan miedzi II, sposób jego wytwarzania i stosowania
PL3091005T3 (pl) Pochodna 1,2-naftochinonu i sposób jej wytwarzania
EP2978011A4 (en) PROCESS FOR PREPARING A COMPLEX AND COMPOSITION
GB201305947D0 (en) New method 1
EP2952519A4 (en) PROTOPANOXADIOL DERIVATIVE, PREPARATION METHOD AND APPLICATION THEREOF
EP3041217A4 (en) Imaging device, method and program
SG11201507951SA (en) Method for producing 2,7-octadien-1-ol
ZA201602129B (en) Audiometry system and method
EP3052484A4 (en) Sulfonylindole derivatives and method for preparing the same
HUE037141T2 (hu) Eljárás 1,1-dibróm-1-fluoretán elõállítására
EP2987794A4 (en) VINBLASTINE DERIVATIVES, PROCESS FOR THEIR SYNTHESIS AND THEIR APPLICATION